Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 46

Sort by

Sort Order Select

Journal Articles

Pentotstatin/TBI Conditioning Is Well-Tolerated and Permits Engraftment of a Second Allogeneic Stem Cell Transplant Following Primary or Secondary Rejection of an Allogeneic Hematopoietic Stem Graft

Ani Gvajaia, MD, Amelia Langston, MD, Natia Esiashvil, MD, Michael Graiser, PhD, Kelly Valla, PharmD, Edmund K. Waller, PhDMD

Blood (2019) 134 (Supplement_1): 5657.

https://doi.org/10.1182/blood-2019-122467

Published: 2019

Journal Articles

Graft-Versus Host Disease Prophylaxis with Postransplantation Bendamustine in Refractory Leaukemia Patients

Ivan S Moiseev, MD PhD, Sergey N. Bondarenko, PhDMD, Elena I Darskaya, MD PhD, Aleksandr Alyanski, Evgeniya Borzenkova, Anna Dotcenko, Olga Kudyasheva, MD, Sergey Lapin, MD PhD, Elena Surkova, PhD, Varvara Nikolaevna Ovechkina, Olga Vladislavovna Pirogova, MD PhD, Valentina Vladimirovna Porunova, MD, Axel Zander, Boris Afanasyev

Blood (2019) 134 (Supplement_1): 5746.

https://doi.org/10.1182/blood-2019-125570

Published: 2019

Journal Articles

Oral Arsenic Trioxide in Front Line Therapy for Acute Promyelocytic Leukemia. A Prospective Costa Rican Study

Mariela Rodriguez, MD, Ronald Rojas, Alejandra Vargas, MD, Miguel Angel Rodriguez, MD, Claudia Garcia, MD, Juliana Esquivel, MD, Jose Gerardo Rojas, MD, Willem Bujan Boza, MD

Blood (2019) 134 (Supplement_1): 3838.

https://doi.org/10.1182/blood-2019-122627

Published: 2019

Journal Articles

Prediction for the Risk of Gvhd after Allogeneic HSCT in Patients with ATL Treated By Mogamulizumab

Yuhei Kamada, MD PhD, Ayako Kuroki, PhD, Naosuke Arima, MD, Maiko Hayashida, MD, Daisuke Nakamura, MD PhD, Makoto Yoshimitsu, MD PhD, Kenji Ishitsuka, MD PhD

Blood (2019) 134 (Supplement_1): 3290.

https://doi.org/10.1182/blood-2019-126912

Published: 2019

Journal Articles

Retrospective Analysis of Outcomes in Acute Myeloid Leukemia (AML) Patients Exposed to Intravenous Contrast Prior to Stem Cell Transplantation

Gayathri Ravi, MD, Yazan Abou-Ismail, MD, Margaret Rothgery, Anjali Shekar, Sophie Golec, Marcos de Lima, MD, Ben Tomlinson, MD

Blood (2018) 132 (Supplement 1): 5179.

https://doi.org/10.1182/blood-2018-99-119293

Published: 2018

Journal Articles

ICOSL + Plasmacytoid Dendritic Cells As Biomarker and Inducer of Graft-Versus-Host Disease

Djamilatou Adom, PhD, Abdulraouf Ramadan, PhD, Kushi Kushekhar, PhD MSc, Sophie Paczesny, MD PhD

Blood (2018) 132 (Supplement 1): 355.

https://doi.org/10.1182/blood-2018-99-116417

Published: 2018

Journal Articles

Adoptive Immunotherapy with Rapidly-Generated Multivirus-Specific T Cells Against AdV, EBV, CMV, HHV6 and BK after Allogeneic Hematopoietic Stem Cell Transplant

Blood (2017) 130 (Supplement 1): 4484.

https://doi.org/10.1182/blood.V130.Suppl_1.4484.4484

Published: 2017

Journal Articles

Rituximab-Based Regimen As First-Line Treatment in Chinese Patients with Follicular Lymphoma: Three-Year Safety Data from a Prospective, Observational Study

Blood (2017) 130 (Supplement 1): 5167.

https://doi.org/10.1182/blood.V130.Suppl_1.5167.5167

Published: 2017

Journal Articles

Interim Results from a Phase 1 Study of ADCT-301 (Camidanlumab Tesirine) Show Promising Activity of a Novel Pyrrolobenzodiazepine-Based Antibody Drug Conjugate in Relapsed/Refractory Hodgkin/Non-Hodgkin Lymphoma

Steven M. Horwitz, MD, Mehdi Hamadani, MD, Michelle A. Fanale, MD, Jay Feingold, MD PhD, Alexander I Spira, MD, Paul A Fields, MD PhD, Tobias Menne, MD PhD, Anand Karnad, MD, Alison J. Moskowitz, MD, Catherine Hildyard, MRCP, BA, Shui He, PhD, Joseph Boni, PhD, Graham Collins, MD PhD

Blood (2017) 130 (Supplement 1): 1510.

https://doi.org/10.1182/blood.V130.Suppl_1.1510.1510

Published: 2017

Journal Articles

Feasibility and Efficacy of High-Dose Chemotherapy and Autologous Hematopoietic Cell Transplantation for HIV-Related Lymphoma: A Single-Institution Experience

Elsa Sleiman, MD, Alexandra Gomez, MD, Julio C. Chavez, MD, Mohamed A Kharfan-Dabaja, MD, Ernesto Ayala, MD

Blood (2016) 128 (22): 5823.

https://doi.org/10.1182/blood.V128.22.5823.5823

Published: 2016

Journal Articles

Pretransplantation Myeloablative Conditioning Regimen with Intravenous Busulfan Dose Adjustment for Older Patients with Hematologic Malignancies

Sabine Fürst, MD, Jean El Cheikh, MD PhD, Bénédicte Devictor, MD, Sandra Cournier, Angela Granata, MD, Samia Harbi, MD, Raynier Devillier, MD PhD, Faezeh Legrand, MD, Stefania Bramanti, MD, Claude Lemarie, PharmD, Jean Pierre Weiller, MD, Catherine Faucher, MD, Christian Chabannon, MD PhD, Borje S. Andersson, MD PhD, Didier Blaise, MD PhD

Blood (2016) 128 (22): 5751.

https://doi.org/10.1182/blood.V128.22.5751.5751

Published: 2016

Journal Articles

Cannabinoid Receptor Signaling As a Target for Personalized Therapy in Aggressive B Cell Lymphomas

Lan Pham, PhD, Juan Chen, PhD, Archie Tamayo, MS, Jerry Bryant, David Yang, PhD, Richard J. Ford, Jr., MD PhD

Blood (2016) 128 (22): 4181.

https://doi.org/10.1182/blood.V128.22.4181.4181

Published: 2016

Journal Articles

Impact of Obesity in Patients with Multiple Myeloma Receiving High-Dose Melphalan Followed By Autologous Hematopoietic Cell Transplantation

Justina Ofori Frimpong, PharmD, BCOP, Rebecca Tombleson, PharmD, BCOP, Melissa Alsina, Jamie Shapiro, PharmD, BCOP, Jongphil Kim, PhD, Binglin Yue, MS, Janelle Perkins, PharmD, BCOP, Taiga Nishihori, MD

Blood (2016) 128 (22): 4636.

https://doi.org/10.1182/blood.V128.22.4636.4636

Published: 2016

Journal Articles

Altered Expression of Functional Proteins in CD4 Regulatory T Cells during Therapy with Idelalisib

Tiago R Matos, MD MSc, Benjamin L Lampson, MD PhD, Masahiro Hirakawa, MD PhD, Siddha Kasar, PhD, Stacey M. Fernandes, Jennifer R. Brown, MD PhD, Jerome Ritz, MD

Blood (2015) 126 (23): 1735.

https://doi.org/10.1182/blood.V126.23.1735.1735

Published: 2015

Journal Articles

Preliminary Results of a Phase I Study of Nivolumab (BMS-936558) in Patients with Relapsed or Refractory Lymphoid Malignancies

Blood (2014) 124 (21): 291.

https://doi.org/10.1182/blood.V124.21.291.291

Published: 2014

Journal Articles

A Novel Th17-Prone CD146 + CCR5 + T-Cell Population As an Early Marker of Intestinal Graft-Versus-Host Disease

Wei Li, PhD, Liangyi Liu, Aurelie Gomez, MD, Qing Zhang, Jilu Zhang, PhD, Abdulraouf Ramadan, PhD, Christen L Mumaw, BS, Joel K. Greenson, MD, Suntrea Hammer, MD, Jingmei Lin, MD PhD, Thomas M. Braun, PhD, Di Jiang, Elizabeth Virts, PhD, Stephanie L Kelich, Hong Wei Chu, MD PhD, Samir Hanash, MD PhD, Helmut Hanenberg, MD, Sophie Paczesny, MD PhD

Blood (2014) 124 (21): 3.

https://doi.org/10.1182/blood.V124.21.3.3

Published: 2014

Journal Articles

Outpatient Administration of High Dose BEAM Chemotherapy As Conditioning for Autologous Stem Cell Transplantation for Lymphoma Results in Fewer Infectious Complications and Improved Survival

Robin M. Reid, MD, Andrea Baran, MS, Paul M. Barr, MD, Michael W. Becker, MD, Steven H. Bernstein, MD, Jonathan W. Friedberg, MD, Jane L. Liesveld, MD, Gordon L. Phillips, MD, Lucy Wedow, FNP, Laurie A. Milner, MD

Blood (2014) 124 (21): 3984.

https://doi.org/10.1182/blood.V124.21.3984.3984

Published: 2014

Journal Articles

Development of a Predictive Pharmacokinetic and Pharmacodynamic Model to Personalize Melphalan Dosing in Autologous Transplant for Patients with Multiple Myeloma

Yu Kyoung Cho, MS, Junan Li, PhD, Douglas W. Sborov, MD, Jiang Wang, PhD, Yue Gao, PhD, Misty Lamprecht, CNS, Ming Poi, PharmD, PhD, Mitch A. Phelps, PhD, Craig C Hofmeister, MD MPH

Blood (2014) 124 (21): 1086.

https://doi.org/10.1182/blood.V124.21.1086.1086

Published: 2014

Journal Articles

The Clinical Relevance of Gastrointestinal Endoscopy in Pediatric Patients with Suspected Gastrointestinal Graft-Versus-Host Disease after Hematopoietic Stem Cell Transplantation

Thomas Mårtensson, MD senior consultant, PhDstudent, Karin Mellgren, MD PhD Associate professor, Jacek Toporski, MD PhD, Jonas Matttson, MD PhD Associate professor, Attila Szakos, MD, Thomas Casswall, MD PhD Associate professor, senior consultant, Britt Gustafsson, Professor, senior consultant

Blood (2014) 124 (21): 3926.

https://doi.org/10.1182/blood.V124.21.3926.3926

Published: 2014

Journal Articles

HLA Polymorphisms and Epstein-Barr Virus Infection In The Recipient Of Allogeneic Hematopoietic Stem Cell Transplantation

Ren Lin, Qian Fan, Sijian Yu, Zhiping Fan, Yu Zhang, Fen Huang, M.D., Hongsheng Zhou, Li Xuan, Meiqing Wu, Xutao Guo, M.D., Min Dai, PhD, Jing Sun, MD, Qifa Liu, M.D.

Blood (2013) 122 (21): 3291.

https://doi.org/10.1182/blood.V122.21.3291.3291

Published: 2013

NARROW

Pentotstatin/TBI Conditioning Is Well-Tolerated and Permits Engraftment of a Second Allogeneic Stem Cell Transplant Following Primary or Secondary Rejection of an Allogeneic Hematopoietic Stem Graft

Graft-Versus Host Disease Prophylaxis with Postransplantation Bendamustine in Refractory Leaukemia Patients

Oral Arsenic Trioxide in Front Line Therapy for Acute Promyelocytic Leukemia. A Prospective Costa Rican Study

Prediction for the Risk of Gvhd after Allogeneic HSCT in Patients with ATL Treated By Mogamulizumab

Retrospective Analysis of Outcomes in Acute Myeloid Leukemia (AML) Patients Exposed to Intravenous Contrast Prior to Stem Cell Transplantation

ICOSL + Plasmacytoid Dendritic Cells As Biomarker and Inducer of Graft-Versus-Host Disease

Adoptive Immunotherapy with Rapidly-Generated Multivirus-Specific T Cells Against AdV, EBV, CMV, HHV6 and BK after Allogeneic Hematopoietic Stem Cell Transplant

Rituximab-Based Regimen As First-Line Treatment in Chinese Patients with Follicular Lymphoma: Three-Year Safety Data from a Prospective, Observational Study

Interim Results from a Phase 1 Study of ADCT-301 (Camidanlumab Tesirine) Show Promising Activity of a Novel Pyrrolobenzodiazepine-Based Antibody Drug Conjugate in Relapsed/Refractory Hodgkin/Non-Hodgkin Lymphoma

Feasibility and Efficacy of High-Dose Chemotherapy and Autologous Hematopoietic Cell Transplantation for HIV-Related Lymphoma: A Single-Institution Experience

Pretransplantation Myeloablative Conditioning Regimen with Intravenous Busulfan Dose Adjustment for Older Patients with Hematologic Malignancies

Cannabinoid Receptor Signaling As a Target for Personalized Therapy in Aggressive B Cell Lymphomas

Impact of Obesity in Patients with Multiple Myeloma Receiving High-Dose Melphalan Followed By Autologous Hematopoietic Cell Transplantation

Altered Expression of Functional Proteins in CD4 Regulatory T Cells during Therapy with Idelalisib

Preliminary Results of a Phase I Study of Nivolumab (BMS-936558) in Patients with Relapsed or Refractory Lymphoid Malignancies

A Novel Th17-Prone CD146 + CCR5 + T-Cell Population As an Early Marker of Intestinal Graft-Versus-Host Disease

Outpatient Administration of High Dose BEAM Chemotherapy As Conditioning for Autologous Stem Cell Transplantation for Lymphoma Results in Fewer Infectious Complications and Improved Survival

Development of a Predictive Pharmacokinetic and Pharmacodynamic Model to Personalize Melphalan Dosing in Autologous Transplant for Patients with Multiple Myeloma

The Clinical Relevance of Gastrointestinal Endoscopy in Pediatric Patients with Suspected Gastrointestinal Graft-Versus-Host Disease after Hematopoietic Stem Cell Transplantation

HLA Polymorphisms and Epstein-Barr Virus Infection In The Recipient Of Allogeneic Hematopoietic Stem Cell Transplantation

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only